CME Listings
Treatment Evolution for Patients with Idiopathic Pulmonary Fibrosis
ResInsightsLive
1
AMA PRA Category 1
Live Course; Enduring Material
Free
October 27, 2015 00:00
4/27/2016
Course Highlights:
- Select potential targets of the IPF disease process that can be leveraged for drug development
- Review new antifibrotic drugs that extend survival and improve quality of life
- Examine key diagnostic methods for definitive diagnosis of IPF
- Identify the hallmark signs and symptoms of IPF
- Explore the advances in defining pathologic features and molecular pathways activated in IPF